Genscript Biotech Reports 2022 Interim Results* ...Middle East

PR Newswire - News
Segment Revenue and Profit Grew Steadily Gene and Cell Therapy CDMO Maintained High Growth Trend Revenue of the Group for the six months ended June 30, 2022 was approximately US$304.7 million, representing an increase of 32.7% as compared with approximately US$229.6 million for the same...

Hence then, the article about genscript biotech reports 2022 interim results was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Genscript Biotech Reports 2022 Interim Results* )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News